Skip to main content
Premium Trial:

Request an Annual Quote

PacBio Signs On Brazilian Distributor for PacBio RS II Platform

NEW YORK (GenomeWeb News) – Pacific Biosciences today announced a distribution deal covering the newly launched PacBio RS II in Brazil.

Under the terms of the deal, PacBio's first distribution agreement in South America, Uniscience do Brasil will exclusively distribute the next-generation sequencing platform in Brazil. PacBio RS II was launched last month. It generates finished genome assemblies, elucidates epigenomes, and characterizes genomic variation, PacBio said.

The platform is based on the Menlo Park, Calif.-based firm's Single Molecule, Real-
Time DNA Sequencing technology, allowing it to generate average read lengths of 5,000 base pairs, "with the longest reads above 20,000 base pairs in length with double the throughput from the previous version of the system," the firm said.

Terms of the deal were not disclosed.

Last week, PacBio partnered with Sage Science to co-market Sage's BluePippin DNA size selection tool for use with the PacBio RS II platform.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.